These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 17039953)

  • 61. The IVD directive: late-phase practicalities.
    Johnson P; Walker R
    Med Device Technol; 2003 Nov; 14(9):35-6. PubMed ID: 14682022
    [No Abstract]   [Full Text] [Related]  

  • 62. Clarification: 510k is premarket notification; it provides no patent or FDA approval.
    Burkhart CG
    J Drugs Dermatol; 2008 Feb; 7(2):105. PubMed ID: 18335644
    [No Abstract]   [Full Text] [Related]  

  • 63. Auditing device clinical studies for US requirements.
    Donawa M
    Med Device Technol; 2007 Oct; 18(6):24-7. PubMed ID: 18078178
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Medical device development: design, engineering, testing, and legal issues protection-steps in the process to success.
    Buchman AL; Spapperi J; Francuzenko KW; Blakeslee MR; Toffenetti J; Leopold P;
    Am J Gastroenterol; 2009 Mar; 104(3):543-5. PubMed ID: 19262512
    [No Abstract]   [Full Text] [Related]  

  • 65. IVD authorized representatives.
    Donawa ME
    Med Device Technol; 2003 May; 14(4):19-21. PubMed ID: 12774572
    [TBL] [Abstract][Full Text] [Related]  

  • 66. An overview of FDA medical device regulation as it relates to deep brain stimulation devices.
    Peña C; Bowsher K; Costello A; De Luca R; Doll S; Li K; Schroeder M; Stevens T
    IEEE Trans Neural Syst Rehabil Eng; 2007 Sep; 15(3):421-4. PubMed ID: 17894274
    [TBL] [Abstract][Full Text] [Related]  

  • 67. FDA's new regulatory paradigms for in vitro diagnostic devices.
    Robinowitz M; Gutman SI
    Cytotherapy; 1999; 1(4):353-7. PubMed ID: 20426566
    [No Abstract]   [Full Text] [Related]  

  • 68. FDA "approval" of medical devices.
    Health Devices; 1999; 28(5-6):235. PubMed ID: 10412079
    [No Abstract]   [Full Text] [Related]  

  • 69. Myths and realities in medical packaging.
    Pilchik R
    Med Device Technol; 2003 Mar; 14(2):16-7. PubMed ID: 12698692
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The U.S. FDA's involvement in the development and utilization of D11.40's standards on rubber consumer products.
    Lin CS; Herman C
    Stand News; 2003 Jul; 31(7):38-41. PubMed ID: 12882219
    [No Abstract]   [Full Text] [Related]  

  • 71. Watchdog group says "massive lobbying effort" by medical device industry threatens public health.
    Lenzer J
    BMJ; 2012 Feb; 344():e1521. PubMed ID: 22374926
    [No Abstract]   [Full Text] [Related]  

  • 72. Medical devices; patient examination and surgeons' gloves; test procedures and acceptance criteria. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2006 Dec; 71(243):75865-79. PubMed ID: 17294550
    [TBL] [Abstract][Full Text] [Related]  

  • 73. New efforts to harmonise clinical evaluation.
    Donawa M
    Med Device Technol; 2006; 17(9):28, 30, 32. PubMed ID: 17240684
    [TBL] [Abstract][Full Text] [Related]  

  • 74. PMA primacy: synthesizing the 35 U.S.C. Section 156 patent term extension, 35 U.S.C. Section 271(e)(1) patent infringement exemption as currently applied to medical devices, and medical device preemption jurisprudence to yield a cohesive solution regarding scope of coverage.
    Flaherty JM
    Food Drug Law J; 2001; 56(3):339-49. PubMed ID: 11944643
    [No Abstract]   [Full Text] [Related]  

  • 75. Remarks by the Commissioner of Food and Drugs at the twentieth anniversary celebration of the 1976 Medical Device Amendments.
    Kessler DA
    Food Drug Law J; 1996; 51(4):501-3. PubMed ID: 11797727
    [No Abstract]   [Full Text] [Related]  

  • 76. Physician modification of legally marketed medical devices: regulatory implications under the federal Food, Drug, and Cosmetic Act.
    Smith JJ
    Food Drug Law J; 2000; 55(2):245-54. PubMed ID: 12269367
    [No Abstract]   [Full Text] [Related]  

  • 77. Medical devices; effective date of requirement for premarket approval for three class III preamendments devices. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2004 Jun; 69(120):34917-20. PubMed ID: 15224687
    [TBL] [Abstract][Full Text] [Related]  

  • 78. From regulation to registration. Safety and performance needs drive industry consensus on voluntary servicing, remarketing controls.
    Hatem MB
    Biomed Instrum Technol; 1999; 33(5):393-8. PubMed ID: 10511908
    [No Abstract]   [Full Text] [Related]  

  • 79. Medical device regulation: an introduction for the practicing physician.
    Maisel WH
    Ann Intern Med; 2004 Feb; 140(4):296-302. PubMed ID: 14970153
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Remarks by the Honorable Paul Rogers at the twentieth anniversary celebration of the 1976 Medical Device Amendments.
    Rogers PG
    Food Drug Law J; 1996; 51(4):505-7. PubMed ID: 11797728
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.